Cannabinoids may change how the liver processes medicines
Selective and Time-Dependent Alterations in Cytochrome P450 (CYP) Enzyme Activity and Expression by Major Phytocannabinoids.
AI Summary
This laboratory study examined whether major cannabis compounds alter cytochrome P450 (CYP) enzymes, which help the liver break down many prescription and over-the-counter medicines. Human liver cells were exposed to THC, CBD, CBN, or a cannabinoid mixture, and researchers measured changes in enzyme activity and gene expression.
The effects depended on both the cannabinoid and the timing of exposure. Longer exposure to CBN and the mixture increased CYP1A2 activity by more than twofold, while THC and the mixture increased CYP3A4 activity and expression by more than twofold at 3 ยตM. In contrast, short-term exposure to CBD, CBN, or the mixture inhibited CYP1A2 in a concentration-dependent manner. The findings suggest that cannabinoids may change how some medicines are metabolized, but this cell-based study does not establish the size of those effects in cannabis users or patients.
๐ก Key Findings
๐
Original Abstract
Related Research
Similar Studies
More THC research papers you might find interesting.
Small lab study finds cannabis affected simulated driving and confidence
A lab method measures 17 cannabinoids across five hemp product types
A single-center study finds varied care and no recurrence in follow-up
Explore More Research
Stay informed about the latest cannabis science.